Prosecution Insights
Last updated: April 19, 2026

Examiner: WEBB, WALTER E

Tech Center 1600 • Art Units: 1612 1658

This examiner grants 46% of resolved cases

Performance Statistics

46.5%
Allow Rate
-13.5% vs TC avg
1037
Total Applications
+19.0%
Interview Lift
1114
Avg Prosecution Days
Based on 977 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
18.8%
§102 Novelty
48.3%
§103 Obviousness
15.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18006482 Inhibitors of the Artemin Pathway for Treatment of Cancer Final Rejection The University of Chicago
18647298 DENTAL POLISHING PASTE CONTAINING NANOPARTICLES Non-Final OA Imam Abdulrahman Bin Faisal University
18655468 METHODS OF USE OF ORAL CARE COMPOSITIONS COMPRISING HOPS Non-Final OA The Procter & Gamble Company
17966131 Oral Care Compositions Comprising Medium Length Polyphosphates Final Rejection The Procter & Gamble Company
17704028 Edible Oral Compositions Comprising Hops Final Rejection The Procter & Gamble Company
18713364 METHOD OF PREPARING BIODEGRADABLE MICROCAPSULES BASED ON GELATINE Non-Final OA SYNGENTA CROP PROTECTION AG
18734661 COSMETIC COMPOSITION INCLUDING AN ALOE-TREATED COLORANT Non-Final OA L'OREAL
18258011 DYEING COMPOSITION BASED ON 2-GAMMA-HYDROXYPROPYL-PARA-PHENYLENEDIAMINE AND ON A PHOSPHORIC SURFACTANT Non-Final OA L'Oreal
18008250 DYEING AND/OR LIGHTENING COMPOSITION COMPRISING AN ANTHRAQUINONE CATIONIC DIRECT DYE, A FATTY SUBSTANCE, A CHEMICAL OXIDIZING AGENT AND A BASIFYING AGENT AND/OR AN OXIDATION DYE PRECURSOR Non-Final OA L'Oreal
16468353 HAIR LIGHTENING COMPOSITION COMPRISING HYDROGEN PEROXIDE, A PEROXYGENATED SALT, A BICARBONATE AND AT LEAST ONE POLYPHOSPHORUS DERIVATIVE Non-Final OA L'OREAL
19105958 LIPID PARTICLE Non-Final OA UNITED IMMUNITY, CO., LTD.
17910728 CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING ALPHA-V-BETA-6 INTEGRIN IN VIVO Final Rejection Technische Universität München
18017074 PHOSPHOLIPID BILAYERS CATALYTICALLY PROMOTE PROTEIN REFOLDING, INHIBIT AND REVERSE PROTEIN AGGREGATE FORMATION, AND METHODS OF TREATING NEURODEGENERATIVE DISEASES USING THE SAME Non-Final OA THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE
18546733 ANTIBACTERIAL AND MINERALIZING COMPOSITIONS AND METHODS OF USE THEREOF Non-Final OA The University of Hong Kong
18294373 DEODORANT COMPOSITIONS Non-Final OA Conopco, Inc., d/b/a UNILEVER
18017468 An Antiperspirant Composition Final Rejection Conopco, Inc., d/b/a UNILEVER
18367118 METHOD FOR IMPROVING THE PHARMACEUTIC PROPERTIES OF MICROPARTICLES COMPRISING DIKETOPIPERAZINE AND AN ACTIVE AGENT Non-Final OA MannKind Corporation
18651043 CITRIC ACID AND LACTIC ACID DISINFECTING SOLUTION FOR SOFT POROUS SURFACES Non-Final OA The Clorox Company
17617991 ROTIGOTINE-CONTAINING PATCH Final Rejection Hisamitsu Pharmaceutical Co., Inc.
18643489 Oral Health Composition Comprising Purified Biosurfactants and/or Their Derivatives Non-Final OA Locus Solutions IPCo, LLC
18005425 COOLING SENSATION COMPOSITIONS Final Rejection GIVAUDAN SA
18615236 MICROEMULSION DELIVERY SYSTEMS INCORPORATED INTO GUMMY CONFECTIONS Non-Final OA Quicksilver Scientific, Inc.
17628639 ANTIMICROBIAL COMPOSITIONS Non-Final OA GOJO Industries, Inc.
18020235 METHODS AND COMPOSITIONS FOR TREATING PERIODONTAL DISEASE Final Rejection University of Louisville Research Foundation, Inc.
18557625 Two Phase System to Administer a Dose of an Active to Animals Final Rejection Shear Kershman Laboratories, Inc.
17619076 SODIUM THIOSULFATE GEL FOR PREVENTING OR REDUCING HEARING LOSS Non-Final OA STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
17918162 ANTIBACTERIAL AGENT AGAINST PERIODONTAL DISEASE-ASSOCIATED BACTERIUM AND DENTAL CARIES-ASSOCIATED BACTERIUM, COMPOSITION FOR PERIODONTAL DISEASE PROPHYLAXIS AND TREATMENT, COMPOSITION FOR CAVITY PROPHYLAXIS AND TREATMENT, COMPOSITION FOR GUM IMPROVEMENT, COMPOSITION FOR GUM RIDGE IMPROVEMENT, COMPOSITION FOR INHIBITING PLAQUE ACCUMULATION, COMPOSITION FOR XEROSTOMIA IMPROVEMENT, COMPOSITION FOR SALIVA IMPROVEMENT, COMPOSITION FOR INHIBITING BAD BREATH, AND COMPOSITION FOR CONSTIPATION IMPROVEMEN Non-Final OA Tokiwa Phytochemical Co., Ltd.
18052390 FLUORIDE COMPOSITION AND METHODS FOR DENTAL MINERALIZATION Final Rejection THE UNIVERSITY OF MELBOURNE
18019634 2-((4S)-6-(4-CHLOROPHENYL)-1-METHYL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-YL)ACETAMIDE FOR TREATING THROMBOCYTHEMIA Final Rejection Constellation Pharmaceuticals, Inc.
18060894 COMPOSITIONS COMPRISING COOLNESS-REGULATING AGENT, AND METHOD OF USE THEREOF Non-Final OA EPC Natural Products Co., Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month